High materiality7/10
Viking Therapeutics price target raised to $87 from $83 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist Financial updates VKTX target to $87; current price $37.98; price change +5.6% since signal.
- PT raised to $87 from $83 by Truist Financial (VKTX).
- Current price $37.98; +5.6% since signal.
Key facts
- 01
Target: $87
- 02
Posted price: $37.98
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.